Symbol Name ID |
Col2a1
collagen, type II, alpha 1 MGI:88452 |
Reference
|
J:310741 Briot A, Jaroszewicz A, Warren CM, Lu J, Touma M, Rudat C, Hofmann JJ, Airik R, Weinmaster G, Lyons K, Wang Y, Kispert A, Pellegrini M, Iruela-Arispe ML, Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells. Dev Cell. 2014 Dec 22;31(6):707-21 |
Age | E13 | E14.5 | E17.5 | P |
Immunohistochemistry (section) | ||||
In situ RNA (section) | ||||
Immunohistochemistry (whole mount) | ||||
In situ RNA (whole mount) | ||||
In situ reporter (knock in) | ||||
Northern blot | ||||
Western blot | ||||
RT-PCR | ||||
cDNA clones | ||||
RNase protection | ||||
Nuclease S1 | ||||
Primer Extension |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|